Form 8-K - Current report:
SEC Accession No. 0001193125-10-167178
Filing Date
2010-07-27
Accepted
2010-07-27 13:54:15
Documents
3
Period of Report
2010-07-26
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d8k.htm 8-K 14755
2 PRESS RELEASE dex991.htm EX-99.1 7422
3 GRAPHIC g47763g91p53.jpg GRAPHIC 7726
  Complete submission text file 0001193125-10-167178.txt   34516
Mailing Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080
Business Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080 4152444990
TITAN PHARMACEUTICALS INC (Filer) CIK: 0000910267 (see all company filings)

EIN.: 943171940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-27436 | Film No.: 10971185
SIC: 2836 Biological Products, (No Diagnostic Substances)